Volume 9 Issue 1
Jan.  2018
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2018  >  9(1): 9-15
Chen Liping. Research progress of cryptococcosis after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002
Citation: Chen Liping. Research progress of cryptococcosis after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2018, 9(1): 9-15. doi: 10.3969/j.issn.1674-7445.2018.01.002
shu

Research progress of cryptococcosis after solid organ transplantation

doi: 10.3969/j.issn.1674-7445.2018.01.002
  • Received Date: 2017-10-24
    Available Online: 2021-01-19
  • Publish Date: 2018-01-15
    Abstract
    • FullText(HTML)
  • loading
    • References(36)
  • [1]
    NEOFYTOS D, FISHMAN JA, HORN D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients[J]. Transpl Infect Dis, 2010, 12(3): 220-229. DOI: 10.1111/j.1399-3062.2010.00492.x.
    [2]
    WANG H, XIAO M, CHEN SC, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2012, 50(12): 3952-3959. DOI: 10.1128/JCM.01130-12.
    [3]
    FANG W, FA Z, LIAO W. Epidemiology of cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015, 78: 7-15. DOI: 10.1016/j.fgb.2014.10.017.
    [4]
    陈敏, 潘炜华, 邓淑文, 等. 格特隐球菌感染病例临床特征分析[C]//2012年中国菌物学会学术年会论文集, 2012: 88.
    [5]
    XUE X, WU H, WANG K, et al. Cryptococcosis by cryptococcus gattii in China[J]. Lancet Infect Dis, 2015, 15(10): 1135-1136. DOI: 10.1016/S1473-3099(15)00301-1.
    [6]
    HENAO-MARTÍNEZ AF, BECKHAM JD. Cryptococcosis in solid organ transplant recipients[J]. Curr Opin Infect Dis, 2015, 28(4): 300-307. DOI: 10.1097/QCO.0000000000000171.
    [7]
    SINGH N, HUPRIKAR S, BURDETTE SD, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice[J]. Am J Transplant, 2012, 12(9): 2414-2428. DOI: 10.1111/j.1600-6143.2012.04100.x.
    [8]
    LIN YY, SHIAU S, FANG CT. Risk factors for invasive cryptococcus neoformans diseases: a case-control study[J]. PLoS One, 2015, 10(3): e0119090. DOI: 10.1371/journal.pone.0119090.
    [9]
    PERFECT JR, BICANIC T. Cryptococcosis diagnosis and treatment: what do we know now[J]. Fungal Genet Biol, 2015, 78: 49-54. DOI: 10.1016/j.fgb.2014.10.003.
    [10]
    SAHA DC, GOLDMAN DL, SHAO X, et al. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients[J]. Clin Vaccine Immunol, 2007, 14(12): 1550-1554. DOI: 10.1128/CVI.00242-07.
    [11]
    邱天文, 朱红梅, 温海, 等.隐球菌侵袭血脑屏障相关机制研究进展[J].中国真菌学杂志, 2016, 11(3): 190-192, 189. DOI: 10.3969/j.issn.1673-3827.2016.03.016.

    QIU TW, ZHU HM, WEN H, et al. Progress in the study of related mechanisms of cryptococcal invasion of the blood brain barrier[J]. Chin J Mycol, 2016, 11(3): 190-192, 189. DOI: 10.3969/j.issn.1673-3827.2016.03.016.
    [12]
    YUCHONG C, FUBIN C, JIANGHAN C, et al. Cryptococcosis in China (1985-2010): review of cases from Chinese database[J]. Mycopathologia, 2012, 173(5/6): 329-335. DOI: 10.1007/s11046-011-9471-1.
    [13]
    OSAWA R, ALEXANDER BD, LORTHOLARY O, et al. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis[J]. Transplantation, 2010, 89(1): 69-74. DOI: 10.1097/TP.0b013e3181bcda41.
    [14]
    YANG YL, CHEN M, GU JL, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases[J]. Int J Infect Dis, 2014, 26: 154-161. DOI: 10.1016/j.ijid.2014.05.028.
    [15]
    HUSAIN S, WAGENER MM, SINGH N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome[J]. Emerg Infect Dis, 2001, 7(3): 375-381. DOI: 10.3201/eid0703.010302.
    [16]
    SINGH N. How I treat cryptococcosis in organ transplant recipients[J]. Transplantation, 2012, 93(1): 17-21. DOI: 10.1097/TP.0b013e318236cd1a.
    [17]
    HUNG MS, TSAI YH, LEE CH, et al. Pulmonary cryptococcosis: clinical, radiographical and serological markers of dissemination[J]. Respirology, 2008, 13(2): 247-251. DOI: 10.1111/j.1440-1843.2007.01202.x.
    [18]
    SHOHAM S, MARR KA. Invasive fungal infections in solid organ transplant recipients[J]. Future Microbiol, 2012, 7(5): 639-655. DOI: 10.2217/fmb.12.28.
    [19]
    BIANCHERI D, KANITAKIS J, BIENVENU AL, et al. Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic features[J]. Eur J Dermatol, 2012, 22(5): 651-657. DOI: 10.1684/ejd.2012.1819.
    [20]
    DESHAYES S, BOUVIER N, CHATELET V, et al. Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab[J]. Transpl Infect Dis, 2016, 18(3): 461-465. DOI: 10.1111/tid.12522.
    [21]
    GUPTA AO, SINGH N. Immune reconstitution syndrome and fungal infections[J]. Curr Opin Infect Dis, 2011, 24(6): 527-533. DOI: 10.1097/QCO.0b013e32834ab20a.
    [22]
    LEGRIS T, MASSAD M, PURGUS R, et al. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient[J]. Transpl Infect Dis, 2011, 13(3): 303-308. DOI: 10.1111/j.1399-3062.2010.00592.x.
    [23]
    HENAO-MARTÍNEZ AF, BECKHAM JD. Cryptococcosis in solid organ transplant recipients[J]. Curr Opin Infect Dis, 2015, 28(4): 300-307. DOI: 10.1097/QCO.0000000000000171.
    [24]
    MAZIARZ EK, PERFECT JR. Cryptococcosis[J]. Infect Dis Clin North Am, 2016, 30(1): 179-206. DOI: 10.1016/j.idc.2015.10.006.
    [25]
    季淑娟, 倪玲红, 张俊丽, 等.不同荚膜抗原检测方法对隐球菌脑膜脑炎诊断和疗效评估的价值[J].中华医学杂志, 2015, 95(46): 3733-3736. DOI: 10.3760/cma.j.issn.0376-2491.2015.46.003.

    JI SJ, NI LH, ZHANG JL, et al. Value of three capsular antigen detection methods in diagnosis and efficacy assessment in patients with cryptococcal meningoencephalitis[J]. Natl Med J China, 2015, 95(46): 3733-3736. DOI: 10.3760/cma.j.issn.0376-2491.2015.46.003.
    [26]
    JARVIS JN, HARRISON TS, LAWN SD, et al. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa[J]. PLoS One, 2013, 8(7): e69288. DOI: 10.1371/journal.pone.0069288.
    [27]
    KABANDA T, SIEDNER MJ, KLAUSNER JD, et al. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid[J]. Clin Infect Dis, 2014, 58(1): 113-116. DOI: 10.1093/cid/cit641.
    [28]
    SINGH N, LORTHOLARY O, DROMER F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings[J]. Transplantation, 2008, 86(5): 647-651. DOI: 10.1097/TP.0b013e3181814e76.
    [29]
    黄铭珊, 金霆.探讨实时荧光定量PCR法检测血液新生隐球菌的临床意义[J].实用检验医师杂志, 2015, 7(1): 28-31. DOI: 10.3969/j.issn.1674-7151.2015.01.008.

    HUANG MS, JIN T. The clinical value of RT-FQ-PCR method for cryptococcus neoformans detection in blood[J]. Chin J Lab Pathol, 2015, 7 (1): 28-31. DOI: 10.3969/j.issn.1674-7151.2015.01.008.
    [30]
    PAPPAS PG, ALEXANDER BD, ANDES DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Clin Infect Dis, 2010, 50(8): 1101-1111. DOI: 10.1086/651262.
    [31]
    PERFECT JR, DISMUKES WE, DROMER F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America[J]. Clin Infect Dis, 2010, 50(3): 291-322. DOI: 10.1086/649858.
    [32]
    BRATTON EW, EL HUSSEINI N, CHASTAIN CA, et al. Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis[J]. Antimicrob Agents Chemother, 2013, 57(6): 2485-2495. DOI: 10.1128/AAC.01800-12.
    [33]
    DAY JN, CHAU TTH, WOLBERS M, et al. Combination antifungal therapy for cryptococcal meningitis[J]. N Engl J Med, 2013, 368(14): 1291-1302. DOI: 10.1056/NEJMoa1110404.
    [34]
    SCEMLA A, GERBER S, DUQUESNE A, et al. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient[J]. Am J Transplant, 2015, 15(2): 560-564. DOI: 10.1111/ajt.13002.
    [35]
    CHEN SC, KORMAN TM, SLAVIN MA, et al. Antifungal therapy and management of complications of cryptococcosis due to cryptococcus gattii[J]. Clin Infect Dis, 2013, 57(4): 543-551. DOI: 10.1093/cid/cit341.
    [36]
    LORTHOLARY O, FERNÁNDEZ-RUIZ M, PERFECT JR. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis)[J]. J Antimicrob Chemother, 2016, 71(suppl 2): ⅱ31-ⅱ36. DOI: 10.1093/jac/dkw394.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (167) PDF downloads(20) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return